Kazemi-Sufi, S., Alipour, S., Rabieepour, M., Roshan-Milani, S., & Naderi, R. (2024, September). Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19. BMC Infectious Diseases.
Chicago Style (17th ed.) CitationKazemi-Sufi, Siamak, Shahriar Alipour, Masome Rabieepour, Shiva Roshan-Milani, and Roya Naderi. "Serum Proinflammatory Cytokines, Receptor Activator of Nuclear Factor Kappa-Β Ligand (RANKL), Osteoprotegerin (OPG) and RANKL/OPG Ratio in Mild and Severe COVID-19." BMC Infectious Diseases Sep. 2024.
MLA (9th ed.) CitationKazemi-Sufi, Siamak, et al. "Serum Proinflammatory Cytokines, Receptor Activator of Nuclear Factor Kappa-Β Ligand (RANKL), Osteoprotegerin (OPG) and RANKL/OPG Ratio in Mild and Severe COVID-19." BMC Infectious Diseases, Sep. 2024.
